Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sprycel
Pharma
After rejection, FDA accepts Xspray's leukemia med resubmission
With a patent feud settled and its application back at the FDA’s desk, Xspray believes it's on track to launch its first product late this summer.
Fraiser Kansteiner
Feb 12, 2024 10:33am
BMS settles with Xspray, clearing way for 2024 Dasynoc launch
Sep 12, 2023 10:16am
FDA rejects Xspray's would-be rival to BMS leukemia med Sprycel
Jul 11, 2023 9:55am
Analyst: BMS earnings may suffer on Sprycel patent loss in EU
Feb 2, 2017 11:00am
